Trent Bishop, PharmD Candidate

AMCP Foundation/Pfizer Oncology Intern
Prime Therapeutics

Poster(s):

• (52) Impact of Medication Adherence on Clinical and Economic Outcomes in Multiple Sclerosis: A Scoping Review of Real-World Evidence
  Wednesday, October 29, 2025

• (292) Real-World patterns of intravenous immunoglobulin (IVIG) and antimicrobial use in members with multiple myeloma treated with chimeric antigen receptor T-cell (CAR T) or bispecific antibody (BsAbs) therapies
  Wednesday, October 29, 2025